Monday, 17 November 2025
AstraZeneca Pharma Poland has renewed its lease for close to 21,000 sq m of office space in the Postępu 14 building in Warsaw’s Mokotów district. Colliers advised the company during the renegotiation process. According to the advisory firm, this is the largest lease transaction on the Warsaw office market in 2025 involving a consulting company.
“Thanks to our cooperation with Colliers, we had a complete overview of office space lease offers from all over Warsaw. The offer from the owner of Postępu 14 was the most advantageous, among other things because it gives us the opportunity to increase the space we occupy as our company continues to grow in Poland. The office is well connected, surrounded by good quality residential and service infrastructure, and meets our high requirements for working and relaxation conditions for several generations of employees. The fact that by staying at Postępu 14, we can continue our operations without having to plan the relocation of several thousand people was also important,” says Michał Janik, Site Executive Director, AstraZeneca Pharma Poland.
According to Colliers representatives Marcin Sabowicz, Aleksandra Baran and Paweł Proński, the decision to remain in the building was influenced in part by ongoing upgrades carried out by the property owner. These include modernisation of common areas such as the reception, the introduction of environmentally friendly solutions and the pursuit of environmental certifications including BREEAM.
“Together with AstraZeneca, we have set a new, highest standard of cooperation between tenants and the building owner in recent years. Our goals in terms of sustainable development and creating a friendly, open working environment are very similar, which is conducive to joint activities and building a lasting relationship. In addition to caring for the technical and functional standards of the office building, we attach great importance to community building initiatives for the Postępu 14 community, which is appreciated by companies such as AstraZeneca. We are therefore all the more pleased with our partner’s decision to extend the lease,” says Dawid Wątorski, Senior Leasing Manager at CA Immo in Poland.
AstraZeneca is a global biopharmaceutical company focused on therapies in oncology, cardiology, pulmonology and neurology. It employs more than 80,000 people worldwide, including around 3,000 in Poland. Warsaw hosts one of the company’s six global clinical research operations centres.
Postępu 14 is a Class A office building in the Mokotów business district, offering more than 34,000 m² of space across ten floors. The property provides over 700 parking spaces and features such as a canteen, café and electric vehicle charging stations. It holds BREEAM certification and has undergone technical and functional upgrades in recent years.
